Literature DB >> 25364523

Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway.

Yao Gao1, Ming Chu1, Jian Hong1, Jingping Shang1, Di Xu1.   

Abstract

BACKGROUND: Cardiac fibrosis following myocardial infarction (MI) results in heart failure. Caveolin-1, the main structural protein of caveolae, regulates signal transduction pathways controlling cell proliferation and apoptosis. Meanwhile, low phosphatase and tensin homolog (PTEN) activity enhances the PI3K/Akt signal pathway to induce cell proliferation. But whether caveolin-1 and PTEN activation regulates cardiac fibroblast proliferation and contributes to cardiac fibrosis from ischemic injury is incompletely understood. This study investigates whether hypoxia inducing cardiac fibroblast proliferation and phenotypic switch is caveolin-dependent.
METHODS: We used in vitro and in vivo models of ischemic injury, immunohistochemical staining, and cell proliferation assays to address this hypothesis.
RESULTS: We found that MI induced collagen deposition and cardiac dysfunction. After MI, mice displayed reduced caveolin-1 and PTEN expression and increased α-smooth muscle actin (α-SMA) expression in the infarct zone. Qualitative and quantitative analyses indicated that caveolin-1 expression was lowest at 7 days after MI, accompanied by increased collagen deposition and attenuated cardiac function. We cultured cardiac fibroblasts of mice were in hypoxia or normoxia conditions for 12, 24 and 48 hours. At all the time points, caveolin-1 and PTEN expression were gradually reduced, whereas, α-SMA was gradually increased. We also observed that cell viability was increased at 12 and 24 h after hypoxia then lightly decreased at 48 h. Additionally, disruption of caveolae with methyl-β-cyclodextrin (MβCD) enhanced p-Akt and α-SMA expression and fibroblast proliferation and phenotypic switch.
CONCLUSIONS: These findings suggest a key role for caveolae, perhaps through the caveolin-1/PTEN signaling pathway, in cardiac fibroblast proliferation and phenotypic switch under hypoxia.

Entities:  

Keywords:  Caveolin-1; cardiac fibroblast; hypoxia; phosphatase and tensin homolog (PTEN)

Year:  2014        PMID: 25364523      PMCID: PMC4215158          DOI: 10.3978/j.issn.2072-1439.2014.08.31

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  52 in total

Review 1.  The multiple faces of caveolae.

Authors:  Robert G Parton; Kai Simons
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 2.  Cavin proteins: New players in the caveolae field.

Authors:  Nolwenn Briand; Isabelle Dugail; Soazig Le Lay
Journal:  Biochimie       Date:  2010-04-02       Impact factor: 4.079

3.  Caveolin-1 deficiency increases cerebral ischemic injury.

Authors:  Jean-François Jasmin; Samit Malhotra; Manjeet Singh Dhallu; Isabelle Mercier; Daniel M Rosenbaum; Michael P Lisanti
Journal:  Circ Res       Date:  2007-02-09       Impact factor: 17.367

4.  Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.

Authors:  P E Scherer; R Y Lewis; D Volonte; J A Engelman; F Galbiati; J Couet; D S Kohtz; E van Donselaar; P Peters; M P Lisanti
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

5.  Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death.

Authors:  Maritza Mayorga; Núria Bahi; Manel Ballester; Joan X Comella; Daniel Sanchis
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

6.  Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.

Authors:  Tuomas Ryhänen; Eliisa Mannermaa; Niku Oksala; Johanna Viiri; Tuomas Paimela; Antero Salminen; Mustafa Atalay; Kai Kaarniranta
Journal:  Eur J Pharmacol       Date:  2008-02-14       Impact factor: 4.432

7.  Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.

Authors:  Svetlana Savin; Dubravka Cvejic; Tijana Isic; Ivan Paunovic; Svetislav Tatic; Marija Havelka
Journal:  Hum Pathol       Date:  2008-07-26       Impact factor: 3.466

Review 8.  Cardiac fibroblast in development and wound healing.

Authors:  Arjun Deb; Eric Ubil
Journal:  J Mol Cell Cardiol       Date:  2014-03-10       Impact factor: 5.000

Review 9.  Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

Authors:  K M Yamada; M Araki
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

10.  Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts.

Authors:  Shao-lei Yi; Xiao-jun Liu; Jing-quan Zhong; Yun Zhang
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

View more
  24 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

2.  ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy.

Authors:  Haiquan Huang; Haifeng Ni; Kunling Ma; Jihong Zou
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling.

Authors:  Jinbao Shi; Weilong Xu; Ruiping Zheng; Huizi Miao; Qiaosheng Hu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

4.  ANO1 inhibits cardiac fibrosis after myocardial infraction via TGF-β/smad3 pathway.

Authors:  Yao Gao; Yan Mei Zhang; Li Jun Qian; Ming Chu; Jian Hong; Di Xu
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

5.  Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes in vitro.

Authors:  Giovanni Stefano Ugolini; Andrea Pavesi; Marco Rasponi; Gianfranco Beniamino Fiore; Roger Kamm; Monica Soncini
Journal:  Elife       Date:  2017-03-18       Impact factor: 8.140

6.  MicroRNA expression profiling involved in doxorubicin-induced cardiotoxicity using high-throughput deep-sequencing analysis.

Authors:  Ying Chen; Yingjie Xu; Zhoufeng Deng; Yin Wang; Ying Zheng; Weihua Jiang; Li Jiang
Journal:  Oncol Lett       Date:  2021-05-26       Impact factor: 2.967

7.  Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation.

Authors:  Maryam Sharifi-Sanjani; Mariah Berman; Dmitry Goncharov; Mohammad Alhamaydeh; Theodore Guy Avolio; Jeffrey Baust; Baojun Chang; Ahasanul Kobir; Mark Ross; Claudette St Croix; Seyed Mehdi Nouraie; Charles F McTiernan; Christine S Moravec; Elena Goncharova; Imad Al Ghouleh
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN.

Authors:  Zun-Ping Ke; Peng Xu; Yan Shi; Ai-Mei Gao
Journal:  Oncotarget       Date:  2016-05-17

9.  miR-19a protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis via PTEN/PI3K/p-Akt pathway.

Authors:  Guochao Sun; Ying Lu; Yingxia Li; Jun Mao; Jun Zhang; Yanling Jin; Yan Li; Yan Sun; Lei Liu; Lianhong Li
Journal:  Biosci Rep       Date:  2017-12-05       Impact factor: 3.840

Review 10.  Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip.

Authors:  Natalie N Khalil; Megan L McCain
Journal:  Front Cardiovasc Med       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.